RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
114 hedge funds and large institutions have $564M invested in Revance Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 43 increasing their positions, 25 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
14% less capital invested
Capital invested by funds: $656M → $564M (-$92.4M)
49% less call options, than puts
Call options by funds: $740K | Put options by funds: $1.46M
Holders
114
Holding in Top 10
2
Calls
$740K
Puts
$1.46M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$9.93M | |
| 3 | +$5.56M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.1M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$2.64M |
Top Sellers
| 1 | -$18M | |
| 2 | -$1.33M | |
| 3 | -$1.05M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$819K |
| 5 |
Goldman Sachs
New York
|
-$762K |